Merck & Co., Inc. (MRK) Liabilities and Equity USD 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
Merck & Co., Inc. quarterly Liabilities and Equity history and growth rate from 2010 to 2024.
  • Merck & Co., Inc. Liabilities and Equity for the quarter ending March 31, 2024 was $106 B, a 1.81% decline year-over-year.
Liabilities and Equity, Quarterly Data (USD)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $106 B -$1.95 B -1.81% Mar 31, 2024 10-Q 2024-05-03
Q4 2023 $107 B -$2.49 B -2.28% Dec 31, 2023 10-Q 2024-05-03
Q3 2023 $107 B -$354 M -0.33% Sep 30, 2023 10-Q 2023-11-03
Q2 2023 $104 B -$2.63 B -2.45% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $108 B +$1.13 B +1.06% Mar 31, 2023 10-Q 2023-05-05
Q4 2022 $109 B +$3.47 B +3.28% Dec 31, 2022 10-K 2024-02-26
Q3 2022 $107 B +$13.6 B +14.5% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $107 B +$16.4 B +18.1% Jun 30, 2022 10-Q 2022-08-05
Q1 2022 $107 B +$15.8 B +17.4% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $106 B +$14.1 B +15.4% Dec 31, 2021 10-K 2023-02-24
Q3 2021 $93.5 B +$3.69 B +4.11% Sep 30, 2021 10-Q 2021-11-05
Q2 2021 $90.7 B +$73 M +0.08% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $90.8 B +$5.93 B +6.99% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 $91.6 B +$7.19 B +8.52% Dec 31, 2020 10-K 2022-02-25
Q3 2020 $89.8 B +$6.47 B +7.76% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $90.6 B +$6.65 B +7.92% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $84.9 B +$2.56 B +3.11% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 $84.4 B +$1.76 B +2.13% Dec 31, 2019 10-K 2021-02-25
Q3 2019 $83.3 B -$1.8 B -2.11% Sep 30, 2019 10-Q 2019-11-05
Q2 2019 $84 B -$1.08 B -1.26% Jun 30, 2019 10-Q 2019-08-06
Q1 2019 $82.4 B -$3.69 B -4.29% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 $82.6 B -$5.24 B -5.96% Dec 31, 2018 10-K 2020-02-26
Q3 2018 $85.1 B -$6.55 B -7.14% Sep 30, 2018 10-Q 2018-11-06
Q2 2018 $85 B -$7.76 B -8.37% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 $86 B -$10.5 B -10.9% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 $87.9 B -$7.51 B -7.87% Dec 31, 2017 10-K 2019-02-27
Q3 2017 $91.7 B -$6.66 B -6.77% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 $92.8 B -$3.67 B -3.81% Jun 30, 2017 10-Q 2017-08-08
Q1 2017 $96.6 B -$2.19 B -2.22% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 $95.4 B -$6.3 B -6.2% Dec 31, 2016 10-K 2018-02-27
Q3 2016 $98.3 B -$2.9 B -2.86% Sep 30, 2016 10-Q 2016-11-07
Q2 2016 $96.5 B -$6.11 B -5.95% Jun 30, 2016 10-Q 2016-08-08
Q1 2016 $98.8 B -$9.59 B -8.85% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 $102 B +$3.51 B +3.58% Dec 31, 2015 10-K 2017-02-28
Q3 2015 $101 B -$576 M -0.57% Sep 30, 2015 10-Q 2015-11-05
Q2 2015 $103 B +$4.72 B +4.83% Jun 30, 2015 10-Q 2015-08-06
Q1 2015 $108 B -$115 M -0.11% Mar 31, 2015 10-Q 2015-05-07
Q4 2014 $98.2 B -$7.48 B -7.08% Dec 31, 2014 10-K 2016-02-26
Q3 2014 $102 B -$4.61 B -4.33% Sep 30, 2014 10-Q 2014-11-10
Q2 2014 $97.9 B -$9.02 B -8.44% Jun 30, 2014 10-Q 2014-08-07
Q1 2014 $108 B +$2.26 B +2.13% Mar 31, 2014 10-Q 2014-05-08
Q4 2013 $106 B -$487 M -0.46% Dec 31, 2013 10-K 2015-02-27
Q3 2013 $106 B +$118 M +0.11% Sep 30, 2013 10-Q 2013-11-07
Q2 2013 $107 B +$1.35 B +1.28% Jun 30, 2013 10-Q 2013-08-07
Q1 2013 $106 B +$691 M +0.66% Mar 31, 2013 10-Q 2013-05-09
Q4 2012 $106 B +$1 B +0.96% Dec 31, 2012 10-K 2014-02-27
Q3 2012 $106 B -$233 M -0.22% Sep 30, 2012 10-Q 2012-11-09
Q2 2012 $106 B -$670 M -0.63% Jun 30, 2012 10-Q 2012-08-07
Q1 2012 $106 B -$356 M -0.34% Mar 31, 2012 10-Q 2012-05-08
Q4 2011 $105 B -$653 M -0.62% Dec 31, 2011 10-K 2013-02-28
Q3 2011 $107 B -$1.31 B -1.21% Sep 30, 2011 10-Q 2011-11-08
Q2 2011 $106 B +$24.5 M +0.02% Jun 30, 2011 10-Q 2011-08-08
Q1 2011 $106 B -$5.73 B -5.13% Mar 31, 2011 10-Q 2011-05-09
Q4 2010 $106 B Dec 31, 2010 10-K 2012-02-28
Q3 2010 $108 B Sep 30, 2010 10-Q 2010-11-08
Q2 2010 $106 B Jun 30, 2010 10-Q 2010-08-06
Q1 2010 $112 B Mar 31, 2010 10-Q 2010-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.